NO20034145L - Fremgangsmåte til å produsere en vaksine - Google Patents

Fremgangsmåte til å produsere en vaksine

Info

Publication number
NO20034145L
NO20034145L NO20034145A NO20034145A NO20034145L NO 20034145 L NO20034145 L NO 20034145L NO 20034145 A NO20034145 A NO 20034145A NO 20034145 A NO20034145 A NO 20034145A NO 20034145 L NO20034145 L NO 20034145L
Authority
NO
Norway
Prior art keywords
vaccine
procedure
producing
Prior art date
Application number
NO20034145A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034145D0 (no
Inventor
Hans Loibner
Helmut Eckert
Otto Dobblohoff-Dier
Ralf Kircheis
Manfred Schuster
Erich Wasserbauer
Guenter Waxenecker
Gottfried Himmler
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Publication of NO20034145D0 publication Critical patent/NO20034145D0/no
Publication of NO20034145L publication Critical patent/NO20034145L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20034145A 2001-03-23 2003-09-17 Fremgangsmåte til å produsere en vaksine NO20034145L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0047001A AT410636B (de) 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes
PCT/AT2002/000091 WO2002080966A2 (de) 2001-03-23 2002-03-20 Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes

Publications (2)

Publication Number Publication Date
NO20034145D0 NO20034145D0 (no) 2003-09-17
NO20034145L true NO20034145L (no) 2003-11-07

Family

ID=3674741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034145A NO20034145L (no) 2001-03-23 2003-09-17 Fremgangsmåte til å produsere en vaksine

Country Status (13)

Country Link
US (1) US20040191242A1 (hu)
EP (1) EP1370289A2 (hu)
JP (1) JP2004524369A (hu)
CN (1) CN1522155A (hu)
AT (1) AT410636B (hu)
BR (1) BR0208641A (hu)
CA (1) CA2441499A1 (hu)
HU (1) HUP0303638A3 (hu)
MX (1) MXPA03008587A (hu)
NO (1) NO20034145L (hu)
PL (1) PL363720A1 (hu)
SK (1) SK11732003A3 (hu)
WO (1) WO2002080966A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
WO2005090403A2 (en) * 2004-03-12 2005-09-29 Biovest International, Inc. Method and apparatus for antibody purification
JP5415963B2 (ja) * 2007-02-21 2014-02-12 オスロ ユニベルシテートシケヒュース ホーエフ 新しい癌マーカー
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
WO2022103871A1 (en) * 2020-11-10 2022-05-19 Wyomingv Immune, Inc. Therapeutic compositions for the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436558A1 (de) * 1994-10-13 1996-04-18 Vitorgan Arzneimittel Gmbh Verfahren zur Herstellung von humanen Impfstoffen gegen allergieauslösende Substanzen
EP0792294A1 (en) * 1994-11-16 1997-09-03 Baxter International Inc. Human antibodies to t-cell receptor peptides and methods for their preparation
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
WO1998026086A1 (en) * 1996-12-11 1998-06-18 University Of Florida Novel methods and compositions for treatment of autoimmune diseases
US7022036B2 (en) * 2003-05-21 2006-04-04 Prototoy Llc Electronic throw-and-catch game

Also Published As

Publication number Publication date
AT410636B (de) 2003-06-25
BR0208641A (pt) 2004-03-09
WO2002080966A2 (de) 2002-10-17
PL363720A1 (en) 2004-11-29
HUP0303638A2 (hu) 2004-01-28
CN1522155A (zh) 2004-08-18
SK11732003A3 (sk) 2004-03-02
ATA4702001A (de) 2002-11-15
HUP0303638A3 (en) 2004-10-28
CA2441499A1 (en) 2002-10-17
JP2004524369A (ja) 2004-08-12
WO2002080966A3 (de) 2003-09-12
MXPA03008587A (es) 2004-06-30
WO2002080966A8 (de) 2003-01-23
NO20034145D0 (no) 2003-09-17
US20040191242A1 (en) 2004-09-30
EP1370289A2 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
CY2011001I2 (el) Εμβολια συνδυασμου για neisseria meningitidis
AU2002353378A8 (en) Vaccine for periodontal disease
NO20025576D0 (no) Fremgangsmåte for å tette en borebrönn
EP1461077A4 (en) POLYVALENT IMMUNOGEN
PL366990A1 (en) Novel vaccine compositon
DK1427444T3 (da) West-nil-vaccine
DE60207790D1 (de) Umreifungsmaschine
GB0130215D0 (en) Vaccine
GB0407935D0 (en) Vaccine
NO20033882D0 (no) Vaksine
EP1381344A4 (en) NEW VACCINE
EP1423141A4 (en) VACCINE
DK1438336T3 (da) Gonadotropiner til follikeldannelse
DE60222336D1 (de) Umreifungsvorrichtung
DE60207081D1 (de) Hybridaufblasvorrichtung
IS6716A (is) Aðferðir við að framleiða sílostasól
DE60200810D1 (de) Biegevorrichtung
NO20034145L (no) Fremgangsmåte til å produsere en vaksine
ITMI20021031A1 (it) Procedimento per preparare policarbonato-polioli
ITMI20021745A1 (it) Procedimento per utilizzare un filatoio.
DE50201194D1 (de) Umreifungsvorrichtung
DE60134051D1 (de) Biegeverfahren
DE60233230D1 (de) Höhenbildsyntheseverfahren
FI20002783A0 (fi) Menetelmä olefiinien konvertoimiseksi
IS6928A (is) Aðferðir til að framleiða mirtasapínmilliefni

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application